SONNET BIOTHERAPEUTICS HOLDINGS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.86 USD | +5.08% |
|
+0.81% | +6.90% |
| Mar. 11 | Traders Anticipate Inflation Report as US Equities Open Lower on Wall Street | MT |
| Mar. 11 | Top Premarket Gainers | MT |
Chart calendar Sonnet BioTherapeutics Holdings, Inc.
188236.5Sj3P2yX4UFxWY8BTeJjjDdZM6SIEUAc1YDrjemA19g.qWS0BlzCrjIwG_hQF6UAu1MTbMq7JCtmr-2TvbrrnKm1W89vOvi3NEkc-A~e30b719f21938e16680c72efdade46c8
Upcoming events on Sonnet BioTherapeutics Holdings, Inc.
Past events on Sonnet BioTherapeutics Holdings, Inc.
| 2024-04-10 09:00 am | American Association for Cancer Research Meeting - Abstract Number: 7181 |
| 2024-02-14 07:30 am | Q1 2024 Earnings Release |
| 2023-12-14 04:15 pm | Q4 2023 Earnings Release |
| 2023-11-02 01:30 pm | Connective Tissue Oncology Society Meeting - Abstract Number: 1566754 |
| 2023-08-31 | Reverse Split: 1 of 22 |
| 2023-08-31 09:00 am | Annual General Meeting |
| 2023-08-14 08:00 am | Q3 2023 Earnings Release |
| 2023-08-07 12:00 pm | BTIG Virtual Biotechnology Conference |
| 2023-06-29 02:40 pm | Cytokine-Based Drug Development Summit - Richard Kenney |
| 2023-06-27 01:00 pm | Cytokine-Based Drug Development Summit - John Cini |
| 2023-05-10 07:30 am | Q2 2023 Earnings Release |
| 2023-04-18 05:00 pm | American Association for Cancer Research Meeting |
| 2023-04-18 01:30 pm | American Association for Cancer Research Meeting - Abstract No: CT245 |
| 2023-02-13 08:00 am | Q1 2023 Earnings Release |
| 2022-11-02 08:30 am | Business Update Call |
| 2022-09-18 | Reverse Split: 1 of 14 |
| 2022-08-15 04:05 pm | Q3 2022 Earnings Release |
| 2022-06-23 09:00 am | Annual General Meeting |
| 2022-05-10 08:15 am | Interim 2022 Earnings Release |
| 2022-04-13 09:00 am | American Association of Cancer Research Meeting - Abstract Number: 4229 |
Annual results
| Fiscal Period | September | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,48 0,00 - | 0,35 0,40 -12.52% | 0,15 0,15 1.47% | 0,12 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | -12,4 |
|
EBIT Million USD | Released Forecast Spread | 0,00 0,00 - | -25,1 -24,7 -1.75% | 0,00 0,00 - | -18,8 -16,7 -12.42% | -8,66 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 0,00 - | -25,0 -24,5 -2.05% | 0,00 0,00 - | -18,8 -16,7 -12.66% | -7,13 |
|
Net income Million USD | Released Forecast Spread | 0,00 0,00 - | -25,0 -24,5 -2.05% | 0,00 0,00 - | -18,8 -16,7 -12.78% | -7,13 |
|
EPS USD | Released Forecast Spread | 0,00 0,00 - | -314 -320 1.92% | -150 -147 -2.4% | -18,1 -28,1 35.51% | -1,76 |
| Announcement Date | 17/12/20 | 17/12/21 | 15/12/22 | 14/12/23 | - |
Quarterly results
| Fiscal Period | September | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,13 0,00 - | 0,10 0,05 90.64% | 0,06 0,05 24.14% | 0,06 0,10 -37.25% | 0,04 0,10 -62.74% | 0,04 0,00 - | 0,04 0,00 - | 0,04 0,02 99.57% | 0,02 0,01 55.25% | 0,01 | 0,02 | 0,02 |
|
EBIT Million USD | Released Forecast Spread | -6,21 -8,68 28.4% | -8,21 -10,0 17.9% | -7,87 -9,00 12.59% | -3,60 -4,38 17.79% | -1,28 -3,64 64.84% | -1,60 | -1,78 | -1,97 | ||||
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -6,20 -8,68 28.56% | -8,21 -10,0 17.92% | -7,88 -9,00 12.48% | -3,68 -4,38 16.04% | -1,17 -3,64 67.87% | 0,55 | -1,77 | -1,96 | ||||
|
Net income Million USD | Released Forecast Spread | -6,20 -8,68 28.56% | -8,21 -10,0 17.92% | -7,88 -9,00 12.48% | -3,68 -4,38 16.04% | -1,17 -3,64 67.87% | 0,55 | -1,77 | -1,96 | ||||
|
EPS USD | Released Forecast Spread | -30,8 -70,8 56.52% | -43,1 -40,0 -7.69% | -40,0 -43,1 7.14% | -37,2 -33,2 -11.92% | -17,6 -24,2 27.27% | -7,48 -10,9 31.31% | -2,86 -6,38 55.17% | -17,3 -4,09 -322.15% | -0,31 -0,86 63.95% | -0,28 | -0,69 | -0,48 |
| Announcement Date | 08/02/22 | 10/05/22 | 15/08/22 | 15/12/22 | 13/02/23 | 10/05/23 | 14/08/23 | 14/12/23 | 14/02/24 | - | - | - |
More events
Past sector events for Sonnet BioTherapeutics Holdings, Inc.
| Today 01:30 am | NOVO NORDISK A/S: Q1 2024 Earnings Release |
| Today | BAUSCH HEALTH COMPANIES INC.: Q1 2024 Earnings Release |
| Today | AMGEN INC.: Q1 2024 Earnings Release |
| 2024-05-01 04:05 pm | CORCEPT THERAPEUTICS INCORPORATED: Q1 2024 Earnings Release |
| 2024-05-01 04:05 pm | JAZZ PHARMACEUTICALS PLC: Q1 2024 Earnings Release |
| 2024-05-01 06:45 am | PFIZER, INC.: Q1 2024 Earnings Release |
| 2024-05-01 03:00 am | HALEON PLC: Q1 2024 Sales and Revenue Release - Trading Statement |
| 2024-05-01 02:00 am | GSK PLC: Q1 2024 Earnings Release |
| 2024-04-30 | INNOVIVA, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | PACIRA BIOSCIENCES, INC.: Q1 2024 Earnings Release (Projected) |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- SONN Stock
- Calendar Sonnet BioTherapeutics Holdings, Inc.
